Cytokines and systemic biomarkers are related to the size of abdominal aortic aneurysms

Cytokine

Volumn 46, Issue 2, 2009, Pages 211-215

  Flondell Sité, Despina ^a   Lindblad, Bengt ^a   Kölbel, Tilo ^a   Gottsäter, Anders ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Aneurysm; Coagulation; Immunology; Inflammation; Risk factors

Indexed keywords

ACTIVATED PROTEIN C; BIOLOGICAL MARKER; CD40 LIGAND; CREATININE; CYTOKINE; ENDOTHELIN; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 3; THROMBIN; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; KRUSKALL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANK SUM TEST; STATISTICAL ANALYSIS; THROMBOCYTE COUNT;

AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, ABDOMINAL; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-6; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEIN C INHIBITOR; STATISTICS AS TOPIC;

EID: 65049092330     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.01.007     Document Type: Article

References (32)

1. Choke E., Cockerhill G., Wilson W.R.W., Sayed S., Dawson J., Loftus I., et al. A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg 30 (2005) 227-244
2. Golledge J., Muller J., Daugherty A., and Norman P. Abdominal aortic aneurysm pathogenesis and implications for management. Arterioscler Thromb Vasc Biol 26 (2006) 2605-2619
3. Lindblad B., Börner G., and Gottsäter A. Factors associated with development of large abdominal aortic aneurysm in middle-aged men. Eur J Vasc Endovasc Surg 30 (2005) 346-352
4. Sandford R.M., Bown M.J., London N.J., and Sayers R.D. The genetic basis of abdominal aortic aneurysms: a review. Eur J Vasc Endovasc Surg 33 (2007) 381-390
5. Wassef M., Baxter B.T., Chisholm R.L., Dalman R.L., Fillinger M.F., Heinecke J., et al. Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute. J Vasc Surg 34 (2001) 730-738
6. Lindholt J.S., and Shi G.-P. Chronic inflammation, immune response and infection in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 31 (2006) 453-463
7. Vainas T., Lubbers T., Stassen F.R., Herngreen S.B., van Dieijen-Visser M.P., Bruggeman C.A., et al. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation 107 (2003) 1103-1105
8. Jones K.G., Brull D.J., Brown L.C., Sian M., Greenhalgh R.M., Humphries S.E., et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103 (2001) 2260-2265
9. Middleton R.K., Lloyd G.M., Bown M.J., Cooper N.J., London N.J., and Sayers R.D. The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: a protein array study. J Vasc Surg 45 (2007) 574-580
10. Newman K.M., Jean-Claude J., Li H., Ramey W.G., and Tilson M.D. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation 90 (1994) II224-II227
11. Dawson J., Cockerhill G.W., Choke E., Belli A.M., Loftus I., and Thompson M.M. Aortic aneurysms secrete interleukin-6 into the circulation. J Vasc Surg 45 (2007) 350-356
12. Juvonen J., Surcel H.M., Satta J., Teppo A.M., Bloigu A., Syrjälä H., et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 17 (1997) 2843-2847
13. Kishimoto T. The biology of interleukin-6. Blood 74 (1989) 1-10
14. Kälsch T., Nguyen X.D., Elmas E., Grebert N., Süselbeck T., Klüter H., et al. Coagulation activation and expression of CD40 ligand on platelets upon in vitro lipopolysaccharide-challenge in patients with unstable angina. Int J Cardiol 111 (2006) 217-223
15. Schönbeck U., Gerdes N., Varo N., Reynolds R.S., Horton D.B., Bavendiek U., et al. Oxidized low-density lipoprotein augments and 3-hydroxy-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells. Circulation 106 (2002) 2888-2893
16. Schönbeck U., and Libby P. CD40 signaling and plaque instability. Circ Res 89 (2001) 1092-1103
17. Moran C.S., McCann M., Karan M., Norman P., Kethheesan N., and Golledge J. Association of osteoprotegerin with human abdominal aortic aneurysm progression. Circulation 111 (2005) 3119-3125
18. Ikeda U., Yamamoto K., Maeda Y., Shimpo M., Kanbe T., and Shimada K. Endothelin-1 inhibits nitric oxide synthesis in vascular smooth muscle cells. Hypertension 29 (1997) 65-69
19. Kölbel T., Strandberg K., Mattiasson I., Stenflo J., and Lindblad B. Activated protein C-protein C inhibitor complex: a new biological marker for aortic aneurysms. J Vasc Surg 43 (2006) 935-939
20. Kölbel T., Strandberg K., Donath T., Mattiasson I., Stenflo J., and Lindblad B. Activated protein c-protein c inhibitor complex in patients with abdominal aortic aneurysms: is it associated with diameter and growth rate?. Vasc Endovasc Surg 42 (2008) 135-140
21. Strandberg K., Svensson A., and Stenflo J. Stabilyte tubes that contain strongly acidic citrate prevent in vitro complex formation between activated protein C and protein C inhibitor. Thromb Haemost 89 (2003) 947-949
22. Yamazumi K., Ojiro M., Okumura H., and Aikou T. An activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm. Am J Surg 175 (1998) 297-301
23. Robless P.A., Okonko D., Lintott P., Mansfield A.O., Mikhailidis D.P., and Stansby G.P. Increased platelet aggregation and activation in peripheral arterial disease. Eur J Vasc Endovasc Surg 25 (2003) 16-22
24. Choke E., Thompson M.M., Dawson J., Wilson W.R., Sayed S., Loftus I.M., et al. Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines. Arterioscler Thromb Vasc Biol 26 (2006) 2077-2082
25. Norman P., Spencer C.A., Lawrence-Brown M.M., and Jamrovik K. C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men. Circulation 110 (2004) 862-866
26. Rohde L.E., Arroyo L.H., Rifai N., Creager M.A., Libby P., Ridker P.M., et al. Plasma concentrations of interleukin-6 and abdominal aortic diameter among subjects without aortic dilatation. Arterioscler Thromb Vasc Biol 19 (1999) 1695-1699
27. Engström G., Börner G., Lindblad B., Janzon L., and Lindgärde F. Incidence of fatal or repaired abdominal aortic aneurysm in relation to inflammation-sensitive plasma proteins. Arterioscler Thromb Vasc Biol 24 (2004) 337-341
28. Yamagishi M., Higashikata T., Ishibashi-Ueda H., Sasaki H., Ogino H., Iihara K., et al. Sustained upregulation of inflammatory chemokine and its receptor in aneurysmal and occlusive atherosclerotic disease: results form tissue analysis with cDNA macroarray and real-time reverse transcriptional polymerase chain reaction methods. Circulation 69 (2005) 1490-1495
29. Franklin I.J., Walton L.J., Greenhalgh R.M., and Powell J.T. The influence of indomethacin on the metabolism and cytokine secretion of human aneurysmal aorta. Eur J Vasc Endovasc Surg 18 (1999) 35-42
30. Lindholt J.S., Sorensen H.T., Michel J.B., Thomsen H.F., and Hennerberg E.W. Low-dose aspirin may prevent growth and later surgical repair of medium-sized abdominal aortic aneurysms. Vasc Endovasc Surg 42 (2008) 329-334
31. Yoshimura K., Aoki H., Ikeda Y., Fujii K., Akiyama N., Furutani A., et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun-N-terminal kinase. Nat Med 11 (2005) 1330-1338
32. Urbonavicius S., Urbonaviciene G., Honoré B., Henneberg E.W., Vorum H., and Lindholt J.S. Potential circulation biomarkers for abdominal aortic aneurysm expansion and rupture-a systematic review. Eur J Vasc Endovasc Surg 36 (2008) 273-280